Recommendations for screening crucially depend on the diagnostic and therapeutic setting.
We do not agree with the authors' statement that aldosteronism is “a relatively common …

In the current issue of the Journal of Hypertension, Mulatero and colleagues [1] addressed
the important issue of a potentially curable form of hypertension being overlooked. They did …

Arterial hypertension is a major public health problem that affects more than 1 billion
patients worldwide, a number that is expected to rise to 1.5 billion1 because of aging of the …

He contended that referral of patients with more severe resistant hypertension might have
led to overestimating the PA prevalence, but no patient had resistant hypertension and only …

Background Primary aldosteronism (PA) is the most frequent cause of secondary
hypertension. Reported prevalences of PA vary considerably because of a large …

Mansoor et al report eight subjects with presumed primary aldosteronism presenting as
“hypertensive emergencies.” 1 This retelling of an old observation is worthy of recognition …

Objective: Primary aldosteronism is a common, yet underdiagnosed, cause of hypertension
and resistant hypertension. It is estimated to be responsible for 6% of all cases of …

We welcome the letter by Tanemoto et al.[1] for giving us an opportunity to discuss and
update our results concerning the study of adrenocorticotrophic hormone (ACTH)-testing …

Objective: To determine the prevalence of primary aldosteronism (PA) in hypertensive
patients presenting to the primary care clinic at The Mount Sinai Hospital, regardless of the …

Journal of Clinical Endocrinology & Metabolism, in which the investigators estimated the
notified incidence of primary aldosteronism (PA) in the general population. The article …